453 related articles for article (PubMed ID: 21550555)
1. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
Morgensztern D; Pennell NA; Subramanian J; Govindan R
Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
[TBL] [Abstract][Full Text] [Related]
2. American society of clinical oncology--41st annual meeting. Immunology.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
[No Abstract] [Full Text] [Related]
3. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
[No Abstract] [Full Text] [Related]
4. Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Cheng H; Merika E; Syrigos KN; Saif MW
JOP; 2011 Jul; 12(4):334-8. PubMed ID: 21737890
[TBL] [Abstract][Full Text] [Related]
5. CT-2584 (Cell Therapeutics).
Bonfil RD
Curr Opin Investig Drugs; 2001 Mar; 2(3):424-7. PubMed ID: 11575717
[TBL] [Abstract][Full Text] [Related]
6. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Oberstein PE; Saif MW
JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
[TBL] [Abstract][Full Text] [Related]
7. Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Dimou AT; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):324-7. PubMed ID: 20601803
[TBL] [Abstract][Full Text] [Related]
8. Neuro-oncology: a selected review of ASCO 2011 abstracts.
Chamberlain MC
Expert Rev Neurother; 2011 Oct; 11(10):1371-7. PubMed ID: 21955193
[TBL] [Abstract][Full Text] [Related]
9. Publication outcomes of phase II oncology clinical trials.
Hoeg RT; Lee JA; Mathiason MA; Rokkones K; Serck SL; Crampton KL; Emmel AE; Severson EA; Go RS
Am J Clin Oncol; 2009 Jun; 32(3):253-7. PubMed ID: 19349853
[TBL] [Abstract][Full Text] [Related]
10. American society of clinical oncology--41st annual meeting.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):525-7. PubMed ID: 15973553
[No Abstract] [Full Text] [Related]
11. How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599.
Dornbusch D; Allegra C; Willey J; Andrews M; Leff R; Epstein J; Jones J; Lokey L; Green MR
Oncologist; 2006 Jan; 11(1):31-8. PubMed ID: 16401711
[TBL] [Abstract][Full Text] [Related]
12. Tezacitabine Hoechst Marion Roussel.
Seley KL
Curr Opin Investig Drugs; 2000 Sep; 1(1):135-40. PubMed ID: 11249589
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology--46th annual meeting.
Al-Shamahi A; Murch L; Kirkham K
IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815
[TBL] [Abstract][Full Text] [Related]
14. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
[TBL] [Abstract][Full Text] [Related]
15. Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
Takimoto CH
Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2.
Walker K
IDrugs; 2007 Aug; 10(8):517-9. PubMed ID: 17665321
[No Abstract] [Full Text] [Related]
17. [Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].
Bompas E; Freyer G; Trillet-Lenoir V
Bull Cancer; 1998 Feb; 85(2):125-7. PubMed ID: 9752328
[No Abstract] [Full Text] [Related]
18. American Society of Clinical Oncology--41st annual meeting. Drug highlights I.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):531-3. PubMed ID: 15973555
[No Abstract] [Full Text] [Related]
19. American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.
Tewari KS
Int J Gynecol Cancer; 2012 Nov; 22(9):1634-9. PubMed ID: 23095779
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
